| Product Name | MF | CAS | Details |
|---|
| 2-(2,4,6-Trihydroxyphenyl)acetic acid | 158519-52-9 | Details |
| Hepatitis C Virus NS3 Genotype 1a protein | Details |
| H-AEQVIFVR-OH | Details |
| EDG8 Blocking Peptide | Details |
| 1-(Oxan-4-yl)propan-1-amine | C8H17NO | 854697-14-6 | Details |
| Chlorsulfuron-5-hydroxy | C12H12ClN5O5S | 81123-38-8 | Details |
| CHI3L1 antibody | Details |
| MES hydrate | C6H15NO5S | 1266615-59-1 | Details |
| 1-[(3-Bromophenyl)methyl]-3-methyl-1H-pyrazole-4-carboxylic acid | C12H11BrN2O2 | 1375471-47-8 | Details |
| 2,6-Dichloro-4-methylpyridine | C6H5Cl2N | 39621-00-6 | Details |
| NDST3 Blocking Peptide | Details |
| RP11-298P3.3 Blocking Peptide | Details |
| H-SLTEILK-OH | Details |
| Graveolone | C14H12O4 | 16499-05-1 | Details |
| 5-(3-Nitrophenyl)-2H-1,2,3,4-tetrazole | C7H5N5O2 | 21871-44-3 | Details |
| N-(2-((2-(4-(2-(2-Hydroxyethoxy)ethyl)piperazine-1-carbonyl)phenyl)thio)phenyl)acetamide | C23H29N3O4S | 1371638-10-6 | Details |
| dl-2-Aminobutyric acid methyl ester hydrochloride | C5H12ClNO2 | 7682-18-0 | Details |
| 4,4,4-Trifluoro-3,3-dimethylbutan-1-amine | C6H12F3N | 1454764-09-0 | Details |
| N-Ethyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]azepan-4-amine dihydrochloride | C12H23ClN4O | 1803599-19-0 | Details |
| Desmethyl fluvoxamine - EP | C14H19F3N2O2 | 192876-02-1 | Details |
| 2-(Hydroxymethyl)pyridine | C6H7NO | 586-98-1 | Details |
| 2-(1-Propylpiperidin-4-yl)-1H-benzo[D]imidazole-7-carboxamide succinate | C20H28N4O5 | 943650-25-7 | Details |
| Methyl 4-Bromopyrimidine-2-carboxylate | C6H5BrN2O2 | 1206250-40-9 | Details |
| cis-2-Phenyl-pyrrolidine-3-carboxylic acid hydrochloride | C11H14ClNO2 | 1187927-05-4 | Details |
| 1-Bromopyrene | C16H9Br | 1714-29-0 | Details |
| 2-Amino-6,6-dioxo-4H,5H,7H-6λ?-thieno[2,3-c]thiopyran-3-carbonitrile | C8H8N2O2S2 | 1153420-28-0 | Details |
| 1H,2H,3H,4H,5H-Pyrido[2,3-b][1,4]diazepine | C8H11N3 | 1384591-76-7 | Details |
| N-(4-Acetylphenyl)-2-iodoacetamide | C10H10INO2 | 596107-48-1 | Details |
| Cytokeratin 8+18 antibody | Details |
| (5-Cyclopropyloxolan-2-yl)methanesulfonyl chloride | C8H13ClO3S | 2137738-16-8 | Details |
| 1,3-Dimethyl-5-(1H-pyrazol-1-yl)-1H-pyrazole-4-carboxylic acid | C9H10N4O2 | 1152565-59-7 | Details |
| N-(2-Methoxyphenyl)pyridine-2-carboxamide | C13H12N2O2 | 85344-72-5 | Details |
| Methyl 4-hydroxybicyclo[2.2.2]octane-1-carboxylate | C10H16O3 | 23062-53-5 | Details |
| N-[(Dimethyl-1,2-oxazol-4-yl)methyl]-N-methylcyclopentanamine | C12H20N2O | 1258693-65-0 | Details |
| 5-Cyclopentyl-3-ethyl-1,2,4-oxadiazole | C9H14N2O | 1865239-83-3 | Details |
| 2-Methyl-3-[2-(morpholin-4-yl)ethoxy]phenol | C13H19NO3 | 1094370-22-5 | Details |
| (E)-Cyclododecene | C12H22 | 1486-75-5 | Details |
| ZNF724P antibody | Details |
| Vismodegib | C19H14Cl2N2O3S | 879085-55-9 | Details |
| Carfilzomib (2R,4S)-diol | C40H59N5O8 | 1541172-75-1 | Details |
| Amoxapine - Bio-X ? | C17H16ClN3O | 14028-44-5 | Details |
| Filociclovir | C11H13N5O3 | 632325-71-4 | Details |
| N-(3-Methoxypropyl)cyclohexanamine hydrochloride | C10H21NO.ClH | 2305254-58-2 | Details |
| 2-Amino-6-chloro-(b-D-ribofuranosyl)purine-5'-triphosphate | C10H15ClN5O13P3 | Details |
| 2-Deschloro aripiprazole | C23H28ClN3O2 | 203395-82-8 | Details |
| 7-Chlorobenzo[b]thiophene-3-methanol | C9H7ClOS | 142181-53-1 | Details |
| Cetearyl alcohol | C18H38O.C16H34O | 67762-27-0 | Details |
| 3-Amino-1,2,5,6,7,8-hexahydroquinolin-2-one | C9H12N2O | 865855-13-6 | Details |
| Diethyl (chlorocarbonyl)phosphonate | C5H10ClO4P | 158421-59-1 | Details |
| 23-(Nonylphenoxy)-3,6,9,12,15,18,21-heptaoxatricosan-1-ol | C31H56O9 | 27177-05-5 | Details |
| 1-(4-Bromobenzyl)-1H-imidazole | C10H9BrN2 | 72459-46-2 | Details |
| 4-Chloro-6-fluoro-8-methylquinoline-3-carbonitrile | C11H6ClFN2 | 1016773-98-0 | Details |
| 1-Pyridin-4-ylmethyl-piperazine dihydrochloride | C10H17Cl2N3 | 1185314-04-8 | Details |
| Micafungin FR-179642 impurity (acid) | C35H52N8O20S | 168110-44-9 | Details |
| 1-(Morpholin-4-yl)-2-phenoxyethan-1-one | C12H15NO3 | 18495-00-6 | Details |
| 2-(3-Oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetaldehyde | C10H9NO3 | 1000771-62-9 | Details |
| 2-[2-(Dimethylamino)ethoxy]pyridine-4-carboxylic acid | C10H14N2O3 | 1208082-41-0 | Details |
| 5-(Difluoromethoxy)-2-fluorobenzonitrile | C8H4F3NO | 1261499-62-0 | Details |
| 1-Methyl-N-(prop-2-en-1-yl)-2,5-dihydro-1H-1,2,3,4-tetrazol-5-imine | C5H9N5 | 1343369-00-5 | Details |
| 1-(2,4-Difluorobenzoyl)piperidine-4-carboxylic acid | C13H13F2NO3 | 700815-59-4 | Details |
| LOC342293 Blocking Peptide | Details |
| 3-Bromo-4-(cyclopentyloxy)-5-methoxybenzoic acid | C13H15BrO4 | 713104-51-9 | Details |
| 1H-Pyrrolo[2,3-c]pyridin-2(3H)-one hydrochloride | C7H7ClN2O | 295327-22-9 | Details |
| 2’-C-Methyl-5-fluorouridine | C10H13FN2O6 | 23643-38-1 | Details |
| 7-Methyl-1,2,3,4-tetrahydroquinoline | C10H13N | 58960-03-5 | Details |
| 6-deoxy-6-mercapto-gamma-cyclodextrin,octakis | C48H80O32S8 | 180839-61-6 | Details |
| 3-Fluoro-4-methoxy-N-methylaniline | C8H10FNO | 1096989-82-0 | Details |
| 1-Hydroxy-3,3-dimethylbutan-2-one | C6H12O2 | 38895-88-4 | Details |
| (Isocyanoimino)triphenylphosphorane | C19H15N2P | 73789-56-7 | Details |
| Brg1 antibody | Details |
| Methyl 3-{[(2-hydroxyphenoxy)sulfonyl]amino}propanoate | C10H13NO6S | 1133725-45-7 | Details |
| 2-(3-Formylphenoxymethyl)benzoic acid | C15H12O4 | 1154270-79-7 | Details |
| 2-Amino-3-[4-(methylsulfanyl)phenyl]propanoic acid hydrochloride | C10H14ClNO2S | 1251924-17-0 | Details |
| 3,4-Dihydro-2H-pyrazolo[1,5-e][1,2,5]thiadiazine-8-carboxylic acid 1,1-dioxide | C6H7N3O4S | 2138111-19-8 | Details |
| 5-(Ethoxycarbonyl)-2-methylpyrazin-1-ium-1-olate | C8H10N2O3 | 51037-35-5 | Details |
| E6446 (dihydrochloride) | C27H36ClN3O3 | 1345675-25-3 | Details |
| Bisnortilidine | C15H19NO2 | 53948-51-9 | Details |
| 2-{1-[(tert-Butoxy)carbonyl]azetidin-3-yl}propanoic acid | C11H19NO4 | 1536183-80-8 | Details |
| 3-(Methylamino)cyclobutan-1-ol hydrochloride | C5H12ClNO | 1375472-99-3 | Details |
| N-Benzyl-1,3-thiazol-2-amine | C10H10N2S | 41593-98-0 | Details |
| 3-(4-Methylphenyl)pent-2-enoic acid | C12H14O2 | 174660-81-2 | Details |
| 1-(1-Methyl-1H-pyrazol-3-yl)piperidin-4-one | C9H13N3O | 1538024-17-7 | Details |
| 3-[(Methylsulfanyl)methyl]-1H-pyrazole | C5H8N2S | 270920-35-9 | Details |
| GDNF Human | Details |
| 5H,6H,7H,8H,9H,10H-Cyclohepta[b]indol-2-amine | C13H16N2 | 126087-49-8 | Details |
| TBC1D16 Blocking Peptide | Details |
| 5-Hydroxy-1-(prop-2-yn-1-yl)piperidin-2-one | C8H11NO2 | 2219371-67-0 | Details |
| 4-(4-Ethylpiperidin-4-yl)morpholine | C11H22N2O | 1380604-41-0 | Details |
| [2,2-Difluoro-1-(hydroxymethyl)cyclopropyl]methanol | C5H8F2O2 | 228580-15-2 | Details |
| H-DSAHGFLK^-OH | Details |
| [2-(3,4-Dimethoxyphenyl)ethyl](2-methylpropyl)amine | C14H23NO2 | 745007-45-8 | Details |
| MAGT1 antibody | Details |
| Erythro-5-hydroxy-L-lysine monohydrochloride | C6H15ClN2O3 | 93923-90-1 | Details |
| 2-Methyl-2-(1-methylcyclopropyl)cyclopropan-1-amine | C8H15N | 1507876-47-2 | Details |
| 4-(1,3,4-Thiadiazol-2-ylsulfanyl)aniline | C8H7N3S2 | 1019121-55-1 | Details |
| Ac-RGDY-NH2 | Details |
| CEA Related, TYACFVSNL | C46H68N10O14S | Details |
| TLE4 antibody | Details |
| 2,2,2-Trifluoro-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol | C6H6F3NOS | 923215-80-9 | Details |
| Ganosporeric acid A | C30H38O8 | 135357-25-4 | Details |
| Product Total： Product Page： | ||||
| 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 | ||||